Publication:
Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test

Simple item page
dc.contributor.authorSALMAN, ANDAÇ
dc.contributor.authorKEPENEKLİ KADAYİFCİ, EDA
dc.contributor.authorsSalman, Andac; Yucelten, Deniz; Cakici, Ozlem Akin; Kadayifci, Eda Kepenekli
dc.date.accessioned2022-03-12T22:28:53Z
dc.date.accessioned2026-01-10T20:59:53Z
dc.date.available2022-03-12T22:28:53Z
dc.date.issued2019
dc.description.abstractAcute generalized exanthematous pustulosis (AGEP) is seen uncommonly in children and sometimes shows atypical clinical features in this population. Patch testing can be used effectively in children for the confirmation of the culprit drug in cases of multiple drug use. Here, we report a rare, pediatric case of ceftriaxone-induced AGEP confirmed by patch testing with subsequent recurrence of the skin eruption.
dc.identifier.doi10.1111/pde.13838
dc.identifier.eissn1525-1470
dc.identifier.issn0736-8046
dc.identifier.pubmed31050838
dc.identifier.urihttps://hdl.handle.net/11424/235334
dc.identifier.wosWOS:000474933900031
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofPEDIATRIC DERMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectacute generalized exanthematous pustulosis
dc.subjectallergy
dc.subjectceftriaxone
dc.subjectdrug reaction
dc.subjectpatch testing
dc.subjectUNCOMMON CONDITION
dc.subjectAGEP
dc.titleAcute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage516
oaire.citation.issue4
oaire.citation.startPage514
oaire.citation.titlePEDIATRIC DERMATOLOGY
oaire.citation.volume36

Files

Collections

Araştırma Çıktıları